Detalhe da pesquisa
1.
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia.
Diabetes Obes Metab
; 25(6): 1557-1565, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749303
2.
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
BMC Endocr Disord
; 19(1): 78, 2019 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337371
3.
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia.
J Diabetes Sci Technol
; : 19322968231197423, 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671755
4.
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
Diabetes Technol Ther
; 24(9): 643-654, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467938
5.
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
Diabetes Technol Ther
; 20(3): 247-256, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29565719